Timeline of Authorization and Reimbursement for Oncology Drugs in Italy in the Last 3 Years
Introduction The main purpose of this analysis was to quantify the time elapsed between the validation date of European Medicines Agency (EMA) centralized procedure and the first purchase of a product by at least 1 Italian health care structure, evaluating different variables that affect the process...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-01-01
|
| Series: | Medicine Access @ Point of Care |
| Online Access: | https://doi.org/10.5301/maapoc.0000007 |